1. Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma
   Yifan Pang et al, 2024, Front. Oncol. CrossRef
2. Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges
   Jun Chang Kong et al, 2024, Front. Immunol. CrossRef
3. Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies
   Christina Angeliki Tsiverioti et al, 2024 CrossRef
4. Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions
   Yan Zhong et al, 2024, Cell Death Discov. CrossRef
5. Revolutionizing the treatment for nasopharyngeal cancer: the impact, challenges and strategies of stem cell and genetically engineered cell therapies
   Chin-King Looi et al, 2024, Front. Immunol. CrossRef
6. Chimeric antigen receptor natural killer cell therapy: A systematic review of preclinical studies for hematologic and solid malignancies
   Arezoo Karamivandishi et al, 2025, Human Immunology CrossRef
7. Monovalent Anti-CD3 Antibodies Effectively Eliminate the TCR-Positive Fraction of TCR-Deleted Allogeneic CAR-T Cells to Prevent GVHD
   Ji Hwan Kim et al, 2024, Immune Netw CrossRef